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ABSTRACT
High resolution proton magnetic resonance spectroscopy (1H MRS) was used
to distinguish between various tumor specimens differing in their malignancy,
tumorigenicity, invasiveness and differentiation. This study investigates those MR-visible
changes on colorectal carcinoma cells which are specifically due to changes in cellular
differentiation. 
A poorly differentiated colorectal carcinoma cell line, SW620, was subjected to
a differentiation inducer, sodium butyrate (NaBT). 3-5 mM NaBT affected growth rate,
morphology, cell cycle phase and activity of brush border marker enzymes indicating
increase in cellular differentiation. 
Viable butyrate-treated cells were examined by 1H MRS. 1-dimensional and 2-
dimensional COSY water-suppressed spectra of 3 mM and 5 mM NaBT-treated cells
were compared with those of untreated control. One and two dimensional MRS was
used to document specific changes in the biochemical profiles of lipid, metabolites and
cell surface fucose. NaBT-induced cells can be differentiated from untreated SW620
cells on the basis of their increased MR-visible unsaturated lipid profile, reduced
concentration of glycosylation intermediates UDP-hexoses, decreased N-acetylation
and complexity of cell surface fucosylation pattern. These spectral data were in
agreement with those obtained from a more differentiated colorectal cell line, SW1222.
Treatment of cells with NaBT also affected other parameters of culture, not
specifically related to cellular differentiation, such as growth phases, sensitivity to
mechanical injury, extracellular pH and glucose concentration. In order to distinguish the
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effects of these parameters on MR spectra from the changes specifically caused by
cellular differentiation, the culture conditions of untreated SW620 were artificially
manipulated prior to the MRS examination. These experiments indicated that both
increased lipid and reduced UDP-hexoses may not be unique to the process of
differentiation, but rather result from environmental changes caused by the treatment.
In order to provide further evidence linking differentiation effects with spectral
changes, SW620 cells were also subjected to other methods of inducing differentiation,
namely treatment with dimethyl sulfoxide, retinoic acid, and replacement of glucose by
galactose in the culture media. Cellular differentiation was only obtained after treatment
with dimethyl sulfoxide. The results of these experiments confirmed that reduction in MR
signals from fucose and N-acetylated compounds is associated with differentiated
phenotype, while the increase in lipid is not. Additionally, dependence of N-acetyl and
UDP-hexose concentration on changes in carbohydrate metabolism has been
demonstrated. 
MRS is able to distinguish colorectal cells according to the degree of their
differentiation. These data may contribute to more accurate diagnosis of tumors by
distinguishing symptoms of dedifferentiation from those of changes in malignant and
metastatic potential. Results presented in this thesis provide chemical evidence in
support of the role of differentiation in the well recognised adenoma-carcinoma
sequence. MRS also provides biochemical information which, in the future, may aid
better understanding of the processes involved in development and progression of
cancer.
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ABBREVIATIONS
1D one-dimensional
2D two-dimensional
1H proton
12C carbon 12 nucleus
13C carbon 13 nucleus
18O oxygen 18 nucleus
31P phosphorus 31 nucleus
a.u. arbitrary units
ATRA all-trans-retinoic acid
Bo external magnetic field
B1 radio frequency magnetic field
cAMP cyclic adenosine monophosphate
CEA carcinoembryonic antigen
Cer ceramide
CH methine
CH2 methylene
CH3 methyl
CH=CH olefinic carbons
Cho choline
Cho-P phosphocholine
CMP citidine monophosphate
CO2 carbon dioxide
COSY COrrelated SpectroscopY (two-dimensional scalar)
CPMG Carr-Purcell-Meiboom-Gill (pulse sequence)
CRC colorectal cancer
CX-1 colorectal carcinoma cell line
dB decibels
D2O deuterium oxide (heavy water)
DMEM Dulbecco’s Modified Eagle Medium
DMSO dimethyl sulfoxide
E energy
EDTA ethylene diamine tetra-acetic acid
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Etn ethanolamine
FBS fetal bovine serum
F1 frequency in the first dimension of a 2D experiment
F2 frequency in the second dimension of a 2D experiment
FID free induction decay
Fuc (I, II, III) fucose 
FT Fourier transformation
G1, G2 cell cycle phases
Gal galactose
GalNAc N-acetyl-galactosamine
Glc glucose
Glc- glucose-free
Glc-/Gal+ substitution of glucose with galactose in the medium
GB Gaussian broadening
GDP guanidine di-phosphate
GlcNAc N-acetyl-glucosamine
GPC glycero-phosphocholine
Gz gradient magnetic field in z direction
h hour
Planck’s constant 
H2O water
H2O2 hydrogen peroxide
H2SO4 sulfuric acid
Hx hydrogens attached to carbon Cx of carbohydrate moieties
HT-29 colorectal carcinoma cell line
HRT-18 colorectal carcinoma cell line
Hz hertz
I nuclear spin
Ins inositol
LAOR L-amino-oxidase reagent
LB Lorentzian broadening
LDH lactate dehydrogenase
Le Lewis antigen, (Lea, Leb, Ley, Lex)
Lys lysine
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M mole; mitotic cell cycle phase
M magnetization vector
MAb monoclonal antibody
MHz megahertz
min. minute
mM millimole
MR magnetic resonance
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
ms millisecond
mm millimeter
n2g delay period in 1D T2-filtered MR experiments where n - number
of                               _ pulses, t=1ms
n number of experiments
NaBT sodium butyrate
NANA, Neu5Ac N-acetyl neuraminic (sialic) acid
NAc N-acetyl
ND not done
NE number of experiments
+N(CH3)3 N-trimethyl
NMR nuclear magnetic resonance
NS number of scans
O1 offset
PBS phosphate buffered saline
PCA perchloric acid
PCR polymerase chain reaction
PCr phosphocreatine
p in T-test probability that two means are equal
PLC phospholipase C
ppm parts per million
RA retinoic acid
Rib ribose
r.f. radio frequency
rpm revolutions per minute
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S cell cycle phase (synthesis)
S.D. standard deviation
SW sweep width
SW1222 colorectal carcinoma cell line
SW620 colorectal carcinoma cell line
t1 time domain in the first dimension
t2 time domain in the second dimension
td doubling time of cell culture
T1 spin-latice relaxation (longitudinal)
T2 spin-spin relaxation (transverse)
TGF-A transforming growth factor A
Thr threonine
Tn cell surface glycoprotein antigen
UDP uridine diphosphate
Ura uracil
x,y,z x, y and z coordinate axes
?,A anomer conformations of carbohydrate molecules or glycosidic
                                  bonds
E gyromagnetic ratio
EGT E-glutamyl transpeptidase
G chemical shift
W nuclear magnetic moment
Wm micrometers
Y frequency
Y1/2 linewidth at half height
q, qo Larmor frequency
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